Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of indinavir sulfate with zidovudine (AZT) and lamivudine in HIV-infected patients who have used AZT for six months or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indinavir sulfate (indinavir)
  • Lamivudine (lamivudine)
  • Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED